Mednet Logo

Do you preform elective nodal irradiation in patients with locally advanced NSCLC who are not candidates for or refuse chemotherapy?

Or do you use standared involved nodal fields, as is done with concurrent chemoRT?
4 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Icahn School of Medicine at Mount Sinai
Answered on

No. Usually if they are not candidates for chemotherapy, there are reasons for it, such as medical comorbidities, that would make you want to limit your radiation fields as well. I would consider treating to a higher dose such as 66 Gy, without systemic therapy.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Cancer Care Centers of Brevard
Answered on

Would not do ENI.

Data presented at ASTRO supports hypofractionation for these patients instead of 60-70 Gy in conventional fractionation without chemo

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · UCLA | VA Greater Los Angeles Healthcare System
Answered on

When thinking through this, one can also consider how Bernie Fisher thought through the issue of "less treatment" (lumpectomy) for cancer and how Blake Cady thought about the futility of treating lymph nodes (spedometers whose removal do not disengage the engine). If the disease is already even regi...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Washington School of Medicine
Answered on

There are mulitple publications from high volume centers showing that omission of ENI did not negatively impact outcomes.

Join for free or sign in to see the full answer